PEAR Annual CFF
$2.15 M
-$161.92 M-98.69%
31 December 2022
Summary:
As of February 5, 2025, PEAR annual cash flow from financing activities is $2.15 million, with the most recent change of -$161.92 million (-98.69%) on December 31, 2022. During the last 3 years, it has fallen by -$10.50 million (-82.97%).PEAR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PEAR Quarterly CFF
$961.00 K
+$603.00 K+168.44%
31 December 2022
Summary:
As of February 5, 2025, PEAR quarterly cash flow from financing activities is $961.00 thousand, with the most recent change of +$603.00 thousand (+168.44%) on December 31, 2022. Over the past year, it has dropped by -$147.01 million (-99.35%).PEAR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PEAR TTM CFF
$2.15 M
-$147.01 M-98.56%
31 December 2022
Summary:
As of February 5, 2025, PEAR TTM cash flow from financing activities is $2.15 million, with the most recent change of -$147.01 million (-98.56%) on December 31, 2022. Over the past year, it has dropped by -$161.92 million (-98.69%).PEAR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PEAR Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -98.7% | -99.3% | -98.7% |
| 3 y3 years | -83.0% | - | - |
| 5 y5 years | -83.0% | - | - |
PEAR Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -98.7% | -99.4% | -98.7% |
Pear Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $2.15 M(-98.7%) | $961.00 K(+168.4%) | $2.15 M(-98.6%) |
| Sept 2022 | - | $358.00 K(-53.0%) | $149.17 M(+2.7%) |
| June 2022 | - | $761.00 K(+914.7%) | $145.23 M(+1.0%) |
| Mar 2022 | - | $75.00 K(-99.9%) | $143.83 M(-12.3%) |
| Dec 2021 | $164.08 M | $147.98 M(-4232.3%) | $164.08 M(+919.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$3.58 M(+462.2%) | $16.10 M(-18.2%) |
| June 2021 | - | -$637.00 K(-103.1%) | $19.68 M(-3.1%) |
| Mar 2021 | - | $20.32 M | $20.32 M |
| Dec 2020 | $91.70 M(+624.6%) | - | - |
| Dec 2019 | $12.66 M | - | - |
FAQ
- What is Pear Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Pear Therapeutics?
- What is Pear Therapeutics annual CFF year-on-year change?
- What is Pear Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pear Therapeutics?
- What is Pear Therapeutics quarterly CFF year-on-year change?
- What is Pear Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pear Therapeutics?
- What is Pear Therapeutics TTM CFF year-on-year change?
What is Pear Therapeutics annual cash flow from financing activities?
The current annual CFF of PEAR is $2.15 M
What is the all time high annual CFF for Pear Therapeutics?
Pear Therapeutics all-time high annual cash flow from financing activities is $164.08 M
What is Pear Therapeutics annual CFF year-on-year change?
Over the past year, PEAR annual cash flow from financing activities has changed by -$161.92 M (-98.69%)
What is Pear Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of PEAR is $961.00 K
What is the all time high quarterly CFF for Pear Therapeutics?
Pear Therapeutics all-time high quarterly cash flow from financing activities is $147.98 M
What is Pear Therapeutics quarterly CFF year-on-year change?
Over the past year, PEAR quarterly cash flow from financing activities has changed by -$147.01 M (-99.35%)
What is Pear Therapeutics TTM cash flow from financing activities?
The current TTM CFF of PEAR is $2.15 M
What is the all time high TTM CFF for Pear Therapeutics?
Pear Therapeutics all-time high TTM cash flow from financing activities is $164.08 M
What is Pear Therapeutics TTM CFF year-on-year change?
Over the past year, PEAR TTM cash flow from financing activities has changed by -$161.92 M (-98.69%)